© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
This channel has partnered with the Brighteon Store and receives a small commission from all sales generated from an affiliate link.
Click the shop now button below to help out this channel.
Despite Trump’s deals with Big Pharma, there is hope. His FDA Commissioner, Senator Kennedy, has shown a desire for transparency and breaking monopolies. Will the administration allow 118 government-backed health claims to finally reach the public? The answer comes in January.
Get the inside analysis on the political landscape in this crucial interview.
#Trump #RFKJr #FDA #Transparency #BigPharma #Kennedy #PoliticalAnalysis
🎥 Watch the full interview at www.brighteon.com/channels/hrreport
G7 Energy Ministers Meet on Strategic Oil Reserve Release Amid Strait of Hormuz Closure
Pentagon labels Anthropic a “supply-chain risk” after dispute over military use of AI
U.S. “doomsday planes” take to the skies amid rising nuclear war fears
Iran’s drone strikes on Amazon data centers signal new era of cyber-physical warfare
The Coming False Flag: Why I Believe the State is Preparing to Sacrifice Americans for a War on Iran
Trump’s ‘Victory’ Over Iran Is a Dangerous Fantasy – Here’s Why Lasting Peace Requires a Starkly Different Path
